Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Hyperlipoproteinemias

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 47 articles:
HTML format



Single Articles


    January 2022
  1. OPOKU E, Berisha S, Brubaker G, Robinet P, et al
    Oxidant resistant human apolipoprotein A-I functions similarly to the unmodified human isoform in delaying atherosclerosis progression and promoting atherosclerosis regression in hyperlipidemic mice.
    PLoS One. 2022;17:e0259751.
    PubMed     Abstract available


  2. TIAN G, Wu Y, Jin X, Zeng Z, et al
    The incidence rate and influence factors of hemolysis, lipemia, icterus in fasting serum biochemistry specimens.
    PLoS One. 2022;17:e0262748.
    PubMed     Abstract available


  3. WALDMANN E, Wu L, Busygina K, Altenhofer J, et al
    Effect of PCSK9 inhibition with evolocumab on lipoprotein subfractions in familial dysbetalipoproteinemia (type III hyperlipidemia).
    PLoS One. 2022;17:e0265838.
    PubMed     Abstract available


  4. WANG SK, Lee MC, Hung CL, Chen HH, et al
    Association between hypertriglyceridemic waist phenotype and hypogonadism in Taiwanese adult men.
    PLoS One. 2022;17:e0265629.
    PubMed     Abstract available


  5. BHATTARAI S, Bista B, Yadav BK, Gynawali P, et al
    Estimation of mean population salt intakes using spot urine samples and associations with body mass index, hypertension, raised blood sugar and hypercholesterolemia: Findings from STEPS Survey 2019, Nepal.
    PLoS One. 2022;17:e0266662.
    PubMed     Abstract available


  6. MCDONALD R, Kuhn K, Nguyen TB, Tannous A, et al
    A randomized clinical trial demonstrating cell type specific effects of hyperlipidemia and hyperinsulinemia on pituitary function.
    PLoS One. 2022;17:e0268323.
    PubMed     Abstract available


  7. ERTURK ZARARSIZ G, Bolat S, Cephe A, Kochan N, et al
    Validation of Friedewald, Martin-Hopkins and Sampson low-density lipoprotein cholesterol equations.
    PLoS One. 2022;17:e0263860.
    PubMed     Abstract available


  8. AL-ASHWAL FY, Sulaiman SAS, Sheikh Ghadzi SM, Kubas MA, et al
    Risk assessment of atherosclerotic cardiovascular diseases before statin therapy initiation: Knowledge, attitude, and practice of physicians in Yemen.
    PLoS One. 2022;17:e0269002.
    PubMed     Abstract available


  9. SHARMA S, Khudiwal A, Bhardwaj S, Chaturvedi H, et al
    Healthcare worker-based opportunistic screening for familial hypercholesterolemia in a low-resource setting.
    PLoS One. 2022;17:e0269605.
    PubMed     Abstract available


  10. EFREMOV Y, Ermolaeva A, Vladimirov G, Gordleeva S, et al
    A mathematical model of in vitro hepatocellular cholesterol and lipoprotein metabolism for hyperlipidemia therapy.
    PLoS One. 2022;17:e0264903.
    PubMed     Abstract available


  11. ALBUQUERQUE J, Medeiros AM, Alves AC, Bourbon M, et al
    Comparative study on the performance of different classification algorithms, combined with pre- and post-processing techniques to handle imbalanced data, in the diagnosis of adult patients with familial hypercholesterolemia.
    PLoS One. 2022;17:e0269713.
    PubMed     Abstract available


  12. ALI SM, Salem FE, Aboulwafa MM, Shawky RM, et al
    Hypolipidemic activity of lactic acid bacteria: Adjunct therapy for potential probiotics.
    PLoS One. 2022;17:e0269953.
    PubMed     Abstract available


  13. ELALEM EG, Jelani M, Khedr A, Ahmad A, et al
    Association of cytochromes P450 3A4*22 and 3A5*3 genotypes and polymorphism with response to simvastatin in hypercholesterolemia patients.
    PLoS One. 2022;17:e0260824.
    PubMed     Abstract available


  14. NAZLI SA, Chua YA, Mohd Kasim NA, Ismail Z, et al
    Familial hypercholesterolaemia and coronary risk factors among patients with angiogram-proven premature coronary artery disease in an Asian cohort.
    PLoS One. 2022;17:e0273896.
    PubMed     Abstract available


  15. HUNG MC, Chen YY
    Association between retinitis pigmentosa and an increased risk of primary angle closure glaucoma: A population-based cohort study.
    PLoS One. 2022;17:e0274066.
    PubMed     Abstract available


  16. LU Z, Li Y, Li AJ, Syn WK, et al
    Loss of GPR40 in LDL receptor-deficient mice exacerbates high-fat diet-induced hyperlipidemia and nonalcoholic steatohepatitis.
    PLoS One. 2022;17:e0277251.
    PubMed     Abstract available


    January 2021
  17. KIM JB, Song WH, Park JS, Youn TJ, et al
    A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemia.
    PLoS One. 2021;16:e0245481.
    PubMed     Abstract available


  18. TANNOUS A, Bradford AP, Kuhn K, Fought A, et al
    A randomised trial examining inflammatory signaling in acutely induced hyperinsulinemia and hyperlipidemia in normal weight women-the reprometabolic syndrome.
    PLoS One. 2021;16:e0247638.
    PubMed     Abstract available


  19. ALHABIB KF, Al-Rasadi K, Almigbal TH, Batais MA, et al
    Familial Hypercholesterolemia in the Arabian Gulf Region: Clinical results of the Gulf FH Registry.
    PLoS One. 2021;16:e0251560.
    PubMed     Abstract available


  20. FERRARA P, Di Laura D, Cortesi PA, Mantovani LG, et al
    The economic impact of hypercholesterolemia and mixed dyslipidemia: A systematic review of cost of illness studies.
    PLoS One. 2021;16:e0254631.
    PubMed     Abstract available


  21. FERRIERES J, Banks V, Pillas D, Giorgianni F, et al
    Screening and treatment of familial hypercholesterolemia in a French sample of ambulatory care patients: A retrospective longitudinal cohort study.
    PLoS One. 2021;16:e0255345.
    PubMed     Abstract available


  22. EKOR M, Owusu Agyei PE, Obese E, Biney RP, et al
    Celecoxib exhibits therapeutic potential in experimental model of hyperlipidaemia.
    PLoS One. 2021;16:e0247735.
    PubMed     Abstract available


  23. BEHBEHANI R, Ali A, Al-Moosa A
    Risk factors and visual outcome of Non-Arteritic Ischemic Optic Neuropathy (NAION): Experience of a tertiary center in Kuwait.
    PLoS One. 2021;16:e0247126.
    PubMed     Abstract available


  24. TRAN DT, Lekhak N, Gutierrez K, Moonie S, et al
    Risk factors associated with cardiovascular disease among adult Nevadans.
    PLoS One. 2021;16:e0247105.
    PubMed     Abstract available


  25. KIM JB, Song WH, Park JS, Youn TJ, et al
    Correction: A randomized, open-label, parallel, multi-center Phase IV study to compare the efficacy and safety of atorvastatin 10 and 20 mg in high-risk Asian patients with hypercholesterolemia.
    PLoS One. 2021;16:e0259072.
    PubMed     Abstract available


  26. DE ALBUQUERQUE P, De Marco V, Vendramini THA, Amaral AR, et al
    Supplementation of omega-3 and dietary factors can influence the cholesterolemia and triglyceridemia in hyperlipidemic Schnauzer dogs: A preliminary report.
    PLoS One. 2021;16:e0258058.
    PubMed     Abstract available


  27. PATEL O, Muller CJF, Joubert E, Rosenkranz B, et al
    Therapeutic effects of an aspalathin-rich green rooibos extract, pioglitazone and atorvastatin combination therapy in diabetic db/db mice.
    PLoS One. 2021;16:e0251069.
    PubMed     Abstract available


  28. NIGUSSIE S, Birhan N, Amare F, Mengistu G, et al
    Rate of glycemic control and associated factors among type two diabetes mellitus patients in Ethiopia: A cross sectional study.
    PLoS One. 2021;16:e0251506.
    PubMed     Abstract available


  29. ALSUWAILEM B, Zamzam A, Syed MH, Greco E, et al
    Elevated plasma levels of NT-proBNP in ambulatory patients with peripheral arterial disease.
    PLoS One. 2021;16:e0253792.
    PubMed     Abstract available


  30. GURZELER E, Ruotsalainen AK, Laine A, Valkama T, et al
    SUR1-E1506K mutation impairs glucose tolerance and promotes vulnerable atherosclerotic plaque phenotype in hypercholesterolemic mice.
    PLoS One. 2021;16:e0258408.
    PubMed     Abstract available


  31. PULIPATI VP, Amblee A, Yap SET, Shaka H, et al
    Hypertriglyceridemia-associated acute pancreatitis: Response to continuous insulin infusion.
    PLoS One. 2021;16:e0260495.
    PubMed     Abstract available


  32. LEE Y, Shin J, Kim Y, Kim DS, et al
    Consumption of single products versus fixed-dose combination medicines for hypertension and hyperlipidemia during 2015-2019 in South Korea.
    PLoS One. 2021;16:e0259467.
    PubMed     Abstract available


  33. SQUIER K, Scott A, Hunt MA, Brunham LR, et al
    The effects of cholesterol accumulation on Achilles tendon biomechanics: A cross-sectional study.
    PLoS One. 2021;16:e0257269.
    PubMed     Abstract available


  34. LIM CY, Ho JS, Huang Z, Gao F, et al
    Public perceptions and knowledge of cholesterol management in a multi-ethnic Asian population: A population-based survey.
    PLoS One. 2021;16:e0256218.
    PubMed     Abstract available


  35. ALFAIFI AA, Lai L, Althemery AU
    Barriers in utilizing lipid-lowering agents in non-institutionalized population in the U.S.: Application of a theoretical framework.
    PLoS One. 2021;16:e0255729.
    PubMed     Abstract available


  36. DESHYCKA R, Sudaryo V, Huang NJ, Xie Y, et al
    Engineered red blood cells carrying PCSK9 inhibitors persistently lower LDL and prevent obesity.
    PLoS One. 2021;16:e0259353.
    PubMed     Abstract available


    January 2020
  37. LIU KL, Tsai WC, Tu HP, Lee CH, et al
    Statin use and the risk of chronic kidney disease in patients with psoriasis: A nationwide cohort study in Taiwan.
    PLoS One. 2020;15:e0237816.
    PubMed     Abstract available


  38. KIM T, Choi H, Kang J, Kim J, et al
    Association between electronic cigarette use and metabolic syndrome in the Korean general population: A nationwide population-based study.
    PLoS One. 2020;15:e0237983.
    PubMed     Abstract available


  39. OCHIAI M
    Evaluating the appropriate oral lipid tolerance test model for investigating plasma triglyceride elevation in mice.
    PLoS One. 2020;15:e0235875.
    PubMed     Abstract available


  40. KYPRIANIDOU M, Panagiotakos D, Faka A, Kambanaros M, et al
    Prevalence of multimorbidity in the Cypriot population; A cross-sectional study (2018-2019).
    PLoS One. 2020;15:e0239835.
    PubMed     Abstract available


  41. THOMAS R, Spence MT, Roy R, Beller E, et al
    A randomised on-line survey exploring how health condition labels affect behavioural intentions.
    PLoS One. 2020;15:e0240985.
    PubMed     Abstract available


  42. SINGH G, Hussain Y, Xu Z, Sholle E, et al
    Comparing a novel machine learning method to the Friedewald formula and Martin-Hopkins equation for low-density lipoprotein estimation.
    PLoS One. 2020;15:e0239934.
    PubMed     Abstract available


  43. JOLL JE 2ND, Clark CR, Peters CS, Raddatz MA, et al
    Genetic ablation of serotonin receptor 2B improves aortic valve hemodynamics of Notch1 heterozygous mice in a high-cholesterol diet model.
    PLoS One. 2020;15:e0238407.
    PubMed     Abstract available


  44. JONES LK, Sturm AC, Seaton TL, Gregor C, et al
    Barriers, facilitators, and solutions to familial hypercholesterolemia treatment.
    PLoS One. 2020;15:e0244193.
    PubMed     Abstract available


  45. ZOU Y, Sheng G, Yu M, Xie G, et al
    The association between triglycerides and ectopic fat obesity: An inverted U-shaped curve.
    PLoS One. 2020;15:e0243068.
    PubMed     Abstract available


  46. ANANTHAKUMAR A, Liu Y, Fernandez CE, Truskey GA, et al
    Modeling statin myopathy in a human skeletal muscle microphysiological system.
    PLoS One. 2020;15:e0242422.
    PubMed     Abstract available


  47. PAWLOS A, Broncel M, Wlazlowska E, Jablonowska E, et al
    Cardiovascular risk and response to lipid lowering therapy in patients with HIV infection according to different recommendations.
    PLoS One. 2020;15:e0244675.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hyperlipoproteinemias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: